Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 581 entries
View as:

Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance

Phase: N/A Priority: Normal
NCT ID: NCT02467010 Org: User:
Start: 09/30/08 End: 07/31/13 Due: 07/31/14

Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)

Phase: N/A Priority: Normal
NCT ID: NCT01047267 Org: User:
Start: 06/30/10 End: 12/31/11 Due: 12/31/12

Development of Small Airway Disease Questionnaire

Phase: N/A Priority: Normal
NCT ID: NCT01360294 Org: User:
Start: 09/30/11 End: 08/31/12 Due: 08/31/13

Prevention of Renal and Vascular Endstage Disease Intervention Trial

Phase: N/A Priority: Normal
NCT ID: NCT03073018 Org: User:
Start: 04/30/98 End: 11/30/03 Due: 11/30/04

Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.

Phase: N/A Priority: Normal
NCT ID: NCT05725876 Org: User:
Start: 01/06/25 End: 01/06/27 Due: 01/06/28

Towards Targeting the ORigin of the Inflammatory Cascade in Allergic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04264377 Org: User:
Start: 02/07/20 End: 12/31/22 Due: 12/31/23

Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT00128895 Org: User:
Start: 06/30/03 End: 12/31/14 Due: 12/31/15

Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™

Phase: N/A Priority: Normal
NCT ID: NCT04249531 Org: User:
Start: 06/01/20 End: 06/01/22 Due: 06/01/23

'Cardiac and Intramuscular Adaptations Following Short-term Exercise Prehabilitation in Unfit Patients Scheduled to Undergo Hepatic- or Pancreatic Surgery'

Phase: N/A Priority: Normal
NCT ID: NCT05772819 Org: User:
Start: 04/01/23 End: 06/01/24 Due: 06/01/25

Improving Personal Recovery After Depression with a Blended Module (STAIRS)

Phase: N/A Priority: Normal
NCT ID: NCT05440812 Org: User:
Start: 10/11/22 End: 05/31/25 Due: 05/31/26

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06094920 Org: User:
Start: 08/05/24 End: 10/30/25 Due: 10/30/26

Validation of the "ExSpiron©" in Patients With ALS

Phase: N/A Priority: Normal
NCT ID: NCT04089696 Org: User:
Start: 09/30/25 End: 09/30/25 Due: 09/30/26

European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus

Phase: N/A Priority: Normal
NCT ID: NCT00127764 Org: User:
Start: 01/31/01 End: 04/30/05 Due: 04/30/06

Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Standard of Care

Phase: N/A Priority: Normal
NCT ID: NCT06940505 Org: User:
Start: 04/01/25 End: 06/01/27 Due: 06/01/28

Paediatric Ards Neuromuscular Blockade Study

Phase: N/A Priority: Normal
NCT ID: NCT02902055 Org: User:
Start: 12/01/19 End: 05/01/24 Due: 05/01/25

Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL

Phase: N/A Priority: Normal
NCT ID: NCT05641428 Org: User:
Start: 10/18/22 End: 12/31/27 Due: 12/31/28

Preventive Heart Rehabilitation to Prevent Complications in Patients Undergoing Elective Open Heart Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02984449 Org: User:
Start: 05/03/17 End: 08/31/25 Due: 08/31/26

Computed Tomographic Angiography or Conventional Coronary Angiography in Clinical Decision Making

Phase: N/A Priority: Normal
NCT ID: NCT00566059 Org: User:
Start: 05/31/06 End: 05/31/07 Due: 05/31/08

Early Obesity Intervention Program Within GECKO Drenthe; a Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT01127412 Org: User:
Start: 12/31/06 End: - Due: -

PD-L1 PET Imaging in Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03520634 Org: User:
Start: 05/22/17 End: 04/12/21 Due: 04/12/22

Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease

Phase: N/A Priority: Normal
NCT ID: NCT06117423 Org: User:
Start: 03/31/24 End: 06/30/25 Due: 06/30/26

Gut Microbiome Dynamics in Metastasized or Irresectable Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03941080 Org: User:
Start: 09/09/20 End: 01/31/26 Due: 01/31/27

Ambrisentan Sotagliflozin and Prevention of Renal Injury; a Randomized Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT06072326 Org: User:
Start: 09/30/25 End: 12/31/27 Due: 12/31/28

SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04889183 Org: User:
Start: 03/14/22 End: 05/28/24 Due: 05/28/25

Magnesium and Vascular Stiffness

Phase: N/A Priority: Normal
NCT ID: NCT03632590 Org: User:
Start: 03/27/18 End: 01/31/20 Due: 01/31/21